TransMedics Group Inc. (NASDAQ: TMDX) open the trading on April 07, 2021, with a bit cautious approach as it glided -2.95% to $33.50. During the day, the stock rose to $37.75 and sunk to $32.32 before settling in for the price of $34.52 at the close. Taking a more long-term approach, TMDX posted a 52-week range of $11.51-$49.50.
Nevertheless, stock’s Earnings Per Share (EPS) this year is 50.70%. This publicly-traded company’s shares outstanding now amounts to $27.16 million, simultaneously with a float of $25.29 million. The organization now has a market capitalization sitting at $949.39 million. At the time of writing, stock’s 50-day Moving Average stood at $34.12, while the 200-day Moving Average is $20.83.
If we measure the efficiency of the company that is accounted for 110 employees. It has generated 233,082 per worker during the last fiscal year. Meanwhile, its income per employee was -261,345. The stock had 3.82 Receivables turnover and 0.20 Total Asset turnover. For the Profitability, stocks gross margin was +63.80, operating margin was -102.91 and Pretax Margin of -112.00.
TransMedics Group Inc. (TMDX) Ownership Facts and Figures
Sometimes it helps to make our mind if we keep our tabs on how bigger investors are working with the stock of the Medical Devices industry. TransMedics Group Inc.’s current insider ownership accounts for 1.50%, in contrast to 79.60% institutional ownership. According to the most recent insider trade that took place on Apr 05, this organization’s VP of Operations sold 3,360 shares at the rate of 36.87, making the entire transaction reach 123,883 in total value, affecting insider ownership by 0. Preceding that transaction, on Apr 01, Company’s President & CEO sold 60,000 for 40.63, making the whole transaction’s value amount to 2,437,871. This particular insider is now the holder of 278,843 in total.
TransMedics Group Inc. (TMDX) Earnings and Revenue Records
So, what does the last quarter earnings report of the company that was made public on 12/30/2020 suggests? It has posted -$0.23 earnings per share (EPS) beating the forecaster’s viewpoint (set at -$0.25) by $0.02. This company achieved a net margin of -112.13 while generating a return on equity of -36.27. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.28 per share during the current fiscal year.
TransMedics Group Inc.’s EPS increase for this current 12-month fiscal period is 50.70% and is forecasted to reach -0.60 in the upcoming year.
TransMedics Group Inc. (NASDAQ: TMDX) Trading Performance Indicators
Let’s observe the current performance indicators for TransMedics Group Inc. (TMDX). It’s Quick Ratio in the last reported quarter now stands at 11.40. The Stock has managed to achieve an average true range (ATR) of 4.74. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 37.09.
In the same vein, TMDX’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -1.20, a figure that is expected to reach -0.29 in the next quarter, and analysts are predicting that it will be -0.60 at the market close of one year from today.
Technical Analysis of TransMedics Group Inc. (TMDX)
[TransMedics Group Inc., TMDX] recent stats showed that its last 5-days Average volume was superior the volume it posted in the year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 10.31% While, its Average True Range was 4.69.
Raw Stochastic average of TransMedics Group Inc. (TMDX) in the period of the previous 100 days is set at 55.21%, which indicates a major rise in contrast to 6.87% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 93.61% that was lower than 93.68% volatility it exhibited in the past 100-days period.